AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Nov 10, 2015
29821_dirs_2015-11-10_1bf5c160-395f-4601-a472-7959fced7b35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-11-09
Reporting Person: Fitzgerald Joseph Michael (EVP & President, CRM)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-09 | Common Stock | S | 26220.0000 | $18.5843 | Disposed | 103925.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68790.0000 | Indirect |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at $18.57 and $18.6101. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.